DOC HEALTHPEAK PROPERTIES, INC.
Real Estate Investment Trusts · NYSE · SEC CIK 765880 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY9.4%
TTM net income YoY1,092.0%
TTM EPS YoY1,000.0%
Revenue 3-yr CAGR12.5%
Net income 3-yr CAGR16.1%
Margins
Gross margin—
Operating margin—
Net margin12.3%
FCF margin—
EBITDA margin—
Returns
ROE4.9%
ROA1.8%
ROIC (approx.)—
Asset turnover0.15x
Leverage & solvency
Liabilities / assets51.8%
Debt / equity1.19x
Current ratio—
Interest coverage—
Cash quality & payout
Operating cash flow / net income3.36x
Accruals ratio-4.3%
Payout ratio223.6%
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $2.82B | $2.70B | $2.18B | $2.06B | $1.90B |
| Cost of revenue | — | $1.07B | $902.06M | $862.99M | $773.28M |
| SG&A expense | $90.42M | $97.16M | $95.13M | $131.03M | $98.30M |
| Interest expense | $305.18M | $280.43M | $200.33M | $172.94M | $157.98M |
| Pretax income | $284.29M | $273.17M | $314.94M | $507.13M | $128.37M |
| Income tax | $9.28M | $4.35M | -$9.62M | -$4.42M | -$3.26M |
| Net income | $71.35M | $243.14M | $306.01M | $500.45M | $505.54M |
| EPS (basic) | 0.10 | 0.36 | 0.56 | 0.92 | 0.93 |
| EPS (diluted) | 0.10 | 0.36 | 0.56 | 0.92 | 0.93 |
| Dividends declared per share | 1.22 | 1.20 | 1.20 | 1.20 | 1.20 |
| Weighted avg. shares (diluted) | 696.04M | 676.23M | 547.27M | 539.15M | 539.24M |
| Banking | |||||
| Loans, net | $606.02M | $655.92M | $218.45M | $374.83M | $415.81M |
| Balance sheet | |||||
| Cash & equivalents | $467.46M | $119.82M | $117.64M | $72.03M | $158.29M |
| Goodwill | $68.53M | $68.53M | $18.03M | $18.00M | $18.00M |
| Intangibles | $654.52M | $817.25M | $314.16M | $418.06M | $519.76M |
| Total assets | $20.34B | $19.94B | $15.70B | $15.77B | $15.26B |
| Long-term debt | $9.85B | $8.72B | $6.88B | $6.50B | $6.17B |
| Total debt | $9.85B | $8.72B | $6.88B | $6.50B | $6.17B |
| Total liabilities | $12.03B | $10.88B | $8.77B | $8.48B | $8.11B |
| Shareholders' equity | $7.50B | $8.40B | $6.35B | $6.65B | $6.52B |
| Net debt | $9.38B | $8.60B | $6.76B | $6.43B | $6.01B |
| Shares outstanding | 695.04M | 699.49M | 547.16M | 546.64M | 539.10M |
| Cash flow statement | |||||
| Operating cash flow | $1.25B | $1.07B | $956.24M | $900.26M | $795.25M |
| Capital expenditure | $894.95M | $736.76M | $774.56M | $961.99M | $759.72M |
| Free cash flow | $357.01M | $333.73M | $181.68M | -$61.73M | $35.53M |
| Investing cash flow | -$1.03B | -$113.80M | -$576.75M | -$876.34M | $531.03M |
| Financing cash flow | $136.11M | -$941.42M | -$337.30M | -$116.53M | -$1.29B |
| Depreciation & amortization | $1.06B | $1.06B | $749.90M | $710.57M | $684.29M |
| Stock-based compensation | $14.41M | $15.54M | $14.48M | $26.46M | $18.20M |
| Dividends paid | $849.10M | $794.78M | $657.02M | $648.05M | $650.08M |
| Share buybacks | $97.14M | $190.69M | $6.52M | $67.84M | $12.84M |
Free plan shows the latest 5 periods; Pro shows all 19 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.